We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 5579N
GlaxoSmithKline PLC
26 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ====================================================================== a) Name Sir Philip Hampton === ======================== ============================================ b) Position/status Non-Executive Chairman === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 2,662.812 ---------- ---------- === ======================== ============================================ d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2016-10-26 === ======================== ============================================ f) Place of the n/a transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Professor Sir Roy Anderson === ======================== =========================================== b) Position/status Independent Non-Executive Director === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 437.462 ---------- ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2016-10-26 === ======================== =========================================== f) Place of the n/a transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================================== a) Name Mr Vindi Banga === ======================== ============================================ b) Position/status Senior Independent Non-Executive Director === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 1,749.848 ---------- ---------- === ======================== ============================================ d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2016-10-26 === ======================== ============================================ f) Place of the n/a transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Ms Stacey Cartwright === ======================== =========================================== b) Position/status Independent Non-Executive Director === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors
for the period of service from 1 July 2016 to 30 September 2016. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 323.341 ---------- ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2016-10-26 === ======================== =========================================== f) Place of the n/a transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Dr Vivienne Cox === ======================== =========================================== b) Position/status Independent Non-Executive Director === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 323.341 ---------- ---------- === ======================== =========================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== =========================================== e) Date of the transaction 2016-10-26 === ======================== =========================================== f) Place of the n/a transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================================== a) Name Ms Lynn Elsenhans === ======================== ============================================== b) Position/status Independent Non-Executive Director === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== ============================================== b) Nature of the Acquisition of notional ADSs under the transaction share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $40.70 1,131.786 --------- ---------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2016-10-26 === ======================== ============================================== f) Place of the n/a transaction === ======================== ============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ======================================================================== a) Name Ms Judy Lewent === ======================== ============================================== b) Position/status Independent Non-Executive Director === ======================== ============================================== c) Initial notification/ Initial notification amendment === ======================== ============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== ============================================== b) Nature of the Acquisition of notional ADSs under the transaction share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== ============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $40.70 454.112 --------- ---------- === ======================== ============================================== d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================== e) Date of the transaction 2016-10-26 === ======================== ============================================== f) Place of the n/a transaction === ======================== ============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================================== a) Name Mr Urs Rohner === ======================== ============================================ b) Position/status Independent Non-Executive Director === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of notional Ordinary Shares transaction under the share allocation arrangements for Independent Non-Executive Directors for the period of service from 1 July 2016 to 30 September 2016. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- ---------- GBP16.43 399.422 ---------- ---------- === ======================== ============================================ d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2016-10-26 === ======================== ============================================ f) Place of the n/a transaction === ======================== ============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQQLFLQBFBFBV
(END) Dow Jones Newswires
October 26, 2016 12:10 ET (16:10 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions